Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Neoplasm Metastasis × Docetaxel × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Esophageal Neoplasms 2 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

trastuzumab deruxtecan 3 eribulin 2 Gemcitabine 2 Capecitabine 2 telisotuzumab vedotin 1 pembrolizumab 1 osimertinib 1 olaparib 1 margetuximab 1 exemestane 1 entrectinib 1 encorafenib 1 dacomitinib 1 capmatinib 1 binimetinib 1 adagrasib 1 abemaciclib 1 Vinorelbine 1 Vemurafenib 1 Trastuzumab 1 Pemetrexed 1 Paclitaxel 1 Imlunestrant 1 Gefitinib 1 Fulvestrant 1 Cisplatin 1 Cetuximab 1 Carboplatin 1 Afatinib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡